Atlas Trials

An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

Clinical trial NCT01894984 · TERMINATED

Trial details

NCT number
NCT01894984
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Status
TERMINATED
Study type
OBSERVATIONAL
Schizophrenia
Start date
2007-01-01
Primary completion
2009-12-01
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.